12 Followers on Owler

InteRNA

InteRNA is a clinical-stage biotechnology company that develops and commercializes miRNA therapeutics for the treatment of cancer. Read more

Roel Schaapveld's photo - CEO of InteRNA

CEO

Roel Schaapveld

CEO Approval Rating

89/100

Founded:

2006

Status:

PrivateIndependent Company

INTERNA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Moderna is a top competitor of InteRNA. Moderna was founded in 2010, and is headquartered in Cambridge, Massachusetts. Like InteRNA, Moderna also competes in the Biotechnology field. Moderna generates $2.7B more revenue vs. InteRNA.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 50 a good estimate for InteRNA's Employee count?

InteRNA Acquisitions

No recent acquisitions found related to InteRNA

InteRNA Funding History

Since InteRNA was founded in 2006, it has participated in 4 rounds of funding. In total InteRNA has raised $34.7M. InteRNA's last funding round was on Feb 2021 for a total of $22.4M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series B
Feb 2021
$22.4M

AurorA Science

Series A
Oct 2015
$10.5M
Equity
Mar 2013
--
Grant
Nov 2010
$1.8M

Since InteRNA was founded in 2006, it has participated in 4 rounds of funding. In total InteRNA has raised $34.7M. InteRNA's last funding round was on Feb 2021 for a total of $22.4M

InteRNA Investments

No recent investments found related to InteRNA

InteRNA News

February 12, 2021Born2Invest

Second investment for AurorA Science, which participates in the round of InteRNA Technologies

AurorA Science had led its first investment last December 2020, participating in the $13.8 million (€... See more »
May 6, 2020MarketScreener

Receives Regulatory Approval for Initiation of Phase I Clinical Trial of INT-1B3 in Patients with Advanced Solid Tumors

(marketscreener.com) -- First-in-human trial will test the safety, pharmacokinetics and preliminary e... See more »
May 15, 20194-traders

InteRNA and UMC Utrecht Publish Preclinical Evidence for Potential of miRNAs in Treatment of Epilepsy

(marketscreener.com) -- Journal of Neuroscience publication demonstrates that antagonizing miR-135a r... See more »
March 25, 20194-traders

Appoints Andrea van Elsas, Ph.D. to Scientific Advisory Board

(marketscreener.com) -- Co-inventor of original CTLA4-antibody and immuno-oncology innovator to expan... See more »
December 25, 2018BioPortfolio

InteRNA Technologies BV Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13112018 Prices from USD $250

SummaryInteRNA Technologies BV InteRNA is a biotechnology company that develops RNA therapeutics for ... See more »
November 9, 2018BioPortfolio

InteRNA Technologies BV Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250

SummaryInteRNA Technologies BV InteRNA is a biotechnology company that develops RNA therapeutics for ... See more »
October 1, 2018BioPortfolio

InteRNA Presents Expanded Preclinical Proofofconcept Data on Lead Oncology Development Candidate INT1B3 at the 14th Annual OTS Meeting

Two poster presentations highlight INT1B3s immunesystem activation and CD8 T celldriven antitumor res... See more »

InteRNA Press Releases

InteRNA Videos

Social Media

InteRNA Headquarters

Jonkerbosplein 52 Nijmegen City Centre

Nijmegen, Gelderland6534

31-24-352-96-33

Driving Directions »

Trending Companies

InteRNA Summary

ABOUT

Overview

InteRNA is a clinical-stage biotechnology company that develops and commercializes miRNA therapeutics for the treatment of cancer. InteRNA was founded in 2006. InteRNA's headquarters is located in Nijmegen, Gelderland, NL 6534. It has raised 34.7M in ...

CEO

InteRNA's CEO, Roel Schaapveld, currently has an approval rating of 89%. InteRNA's primary competitors are Moderna, CytomX & Regulus.

Frequently Asked Questions about InteRNA

  1. When was InteRNA founded?

    InteRNA was founded in 2006
  2. Who is InteRNA's CEO?

    InteRNA's CEO is Roel Schaapveld
  3. How much revenue does InteRNA generate?

    InteRNA generates $3M in revenue
  4. How much funding does InteRNA have?

    InteRNA has historically raised $34.7M in funding
  1. Where is InteRNA's headquarters?

    InteRNA's headquarters is in Nijmegen Gelderland, NL
  2. How many employees does InteRNA have?

    InteRNA has 50 employees
  3. What sector does InteRNA operate in?

    InteRNA is in Biotechnology, Pharmaceuticals
  4. Who are InteRNA's competitors?

    InteRNA's top competitors are Moderna, CytomX, Regulus